Skip to main content
SpringerLink
Log in

Preparing for and Responding to Bioterrorist Attacks

The Role of Disease Management Initiatives

  • Current Opinion
  • Published:
Disease Management & Health Outcomes

Abstract

Components of disease management that are applicable to the development of services for bioterrorism preparedness and response include collaborative practice models, population identification processes, reporting/feedback loops, process and outcome measurements, patient self-management education, and evidence-based practice guidelines. This management system should be flexible and applicable to all possible diseases associated with bioterrorism, while including specific management recommendations for each disease.

There are many gaps in the US’s ability to respond to a bioterrorist attack that can only be filled by collaborative research among disciplines involved with bioterrorism preparedness; namely, basic, clinical, and behavioral sciences, public health, and law. Laboratory scientists will need to develop new and improved diagnostic tests, treatments, and protective measures. Behavioral science will have to treat many victims, both the sick and the ‘worried well’. While some states have adequate laws in place to facilitate public health authorities’ efforts to isolate sick patients and quarantine those exposed, many states do not, and their laws will require modification. Public health agencies must develop and evaluate information technologies and decision support systems for the early detection of a bioterrorist attack, for the tracking of victims who will require prophylactic treatment, and to assist physicians with diagnosis and treatment. Public health and hospitals must also prepare for the treatment of large numbers of patients by increasing surge capacity. Finally, one of the most notable deficiencies in response to recent bioterrorism events has been the inability of public health to provide timely and accurate information. Effective communication is a fundamental element of all aspects of an effective response to emergencies. Before a bioterrorist attack, the nation’s preparedness efforts should be evaluated through tabletop and full-scale exercises that are preceded by extensive professional and community education.

The US Army Medical Research Institute of Infectious Diseases has identified six primary agents that may be potentially used in bioterrorism: Bacillus anthracis, variola virus, Yersinia pestis, Francisella tularensis, botulinum toxin, and the hemorrhagic fever viruses. These six were identified on the basis of the following criteria: availability of the agent, ease of production, lethality, infectivity, and stability. Disease management requires an understanding of exposure mechanisms and dose response because the route of exposure and the dose will impact on the way a disease presents. In addition to disease management strategies for bioterrorism in general, this article briefly reviews specific diagnosis, treatment, and infection control recommendations for the six primary bioterrorism diseases agents.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Table I
Table II

Similar content being viewed by others

References

  1. Mina B, Dym JP, Kuepper F, et al. Fatal inhalational anthrax with unknown source of exposure in a 61-year-old woman in New York city. JAMA 2002; 287: 858–62

    Article  PubMed  Google Scholar 

  2. Department of Homeland Security. National response plan. Washington, DC: Department of Homeland Security, 2004

    Google Scholar 

  3. Hick JL, Hanfling D, Burstein JL, et al. Health care facility and community strategies for patient care surge capacity. Ann Emerg Med 2004; 44: 1–11

    Article  Google Scholar 

  4. American Hospital Association. Hospital statistics 2002. Chicago (IL): American Hospital Association, 2002

    Google Scholar 

  5. Wysocki B, Lueck S. Just-in-time inventories make US vulnerable in a pandemic. Wall Street Journal 2006 Jan 12: 1

    Google Scholar 

  6. Agency for Healthcare Research and Quality. Bioterrorism and health system preparedness: addressing surge capacity in a mass casualty event. Issue brief no. 9. AHRQ publication no. 06-0027 [online]. Rockville (MD): Agency for Healthcare Research and Quality, 2006. Available from URL: http://www.ahrq.gov/news/ulp/btbriefs/btbrief9.pdf [Accessed 2006 Sep 8]

  7. Health Systems Research, Inc. Bioterrorism and other public health emergencies: altered standards of care in mass casualty events. AHRQ publication no. 05-0043 [online]. Rockville (MD): Agency for Healthcare Research and Quality, 2005, Available from URL: http://www.ahrq.gov/research/altstand/altstand.pdf [Accessed 2006 Sep 8]

  8. Gostin LO, Sapsin JW, Teret SP, et al. The Model State Emergency Health Powers Act: planning for and response to bioterrorism and naturally occurring disasters. JAMA 2002 Aug 7; 288: 622–8

    Article  PubMed  Google Scholar 

  9. Bravata D, McDonald K, Owens D, et al. Bioterrorism preparedness and response: use of information technologies and decision support systems. Evidence report/technology assessment no. 59. AHRQ publication no. 02-E028 [online]. Rockville (MD): Agency for Healthcare Research and Quality. June 2002. Available from URL: http://www.ahrq.gov/downloads/pub/evidence/pdf/bioit/bioit.pdf [Accessed 2006 Sep 8]

  10. Agency for Healthcare Research and Quality. Web conference: the role of information/communication technology and monitoring/surveillance systems in bioterrorism preparedness. Rockville (MD): Agency for Healthcare Research and Quality, 2003 Oct 21. Available from URL: http://www.ahrq.gov/news/ulp/btinfoaud/ [Accessed 2006 Sep 8]

    Google Scholar 

  11. Brennan PF. AMIA recommendations for national health threat surveillance and response. J Am Med Inform Assoc 2002; 9: 202–6

    Article  PubMed  Google Scholar 

  12. Goldenberg A, Shmueli G, Caruana RA, et al. Early statistical detection of anthrax outbreaks by tracking over-the-counter medication sales. Proc Natl Acad Sci USA 2002; 99: 5237–40

    Article  PubMed  CAS  Google Scholar 

  13. Green MS, Kaufman Z. Surveillance for early detection and monitoring of infectious disease outbreaks associated with bioterrorism. IMAJ 2002; 4: 503–6

    PubMed  Google Scholar 

  14. Institute of Medicine and National Research Council. Detection and measurement of biological agents. In: Institute of Medicine and National Research Council. Chemical and biological terrorism: research and development to improve civilian medical response. Washington, DC: National Academies Press, 1999: 78–96. Available from URL: http://darwin.nap.edu/books/0309061954/html [Accessed 2006 Sep 8]

    Google Scholar 

  15. Nicoll A, Murray V. Health protection — a strategy and a national agency. Public Health 2002; 116: 129–37

    PubMed  CAS  Google Scholar 

  16. Teutsch SM, Churchill, RE. Principles and practice of public health surveillance. Oxford: Oxford University Press, 2000

    Google Scholar 

  17. Wagner MM, Tsui FC, Espino JU, et al. The emerging science of very early detection of disease outbreaks. J Public Health Manag Pract 2001; 7: 51–9

    PubMed  CAS  Google Scholar 

  18. Zelicoff A, Brillman J, Forslund DW, et al. The rapid syndrome validation project [abstract]. American Medical Informatics Association 2001 Annual Symposium; 2001 Nov 3–7; Washington, DC, 771–775

    Google Scholar 

  19. Gerberding JL, Hughes JM, Koplan JP. Bioterrorism preparedness and response: clinician and public health agencies as essential partners [editorial? JAMA 2002; 287: 898–9

    Article  PubMed  Google Scholar 

  20. US Centers for Disease Control and Prevention. Health alert network [online]. Available from URL: http://www2a.cdc.gov/han/index.asp [Accessed 2006 Oct 2]

  21. Evans RG, Crutcher JM, Shadel BN, et al. Terrorism from a public health perspective. Am J Med Sci 2002; 323: 292–8

    Article  Google Scholar 

  22. Inglesby TV, Grossman, R, et al. A plague on your city: observations from TOPOFF. Clin Infect Dis 2001; 32: 436

    Article  PubMed  CAS  Google Scholar 

  23. Lillibridge SR. HHS bioterrorism preparedness: testimony before the Subcommittee on Oversight and Investigations, Committee on Energy and Commerce [online]. Available from URL: http://www.hhs.gov/asl/testify/t011010a.html [Accessed 2006 Sep 8]

  24. O’Toole T, Inglesby T. Shining light on Dark Winter. Biodefense Quarterly 2001; 3: 1–11

    Google Scholar 

  25. O’Toole T, Mair, M, et al. Shining light on “Dark Winter”. Clin Infect Dis 2002; 34: 972–83

    Article  PubMed  Google Scholar 

  26. Illinois issues TOPOFF II report. Fire Chief 2003 Oct 29

  27. Office for Domestic Preparedness, US Department of Homeland Security. Homeland security exercise and evaluation program. Volume II: Exercise evaluation and improvement. NCJ number 202198 [online]. Rockville (MD): US Department of Homeland Security, 2003. Available from URL: http://www.ojp.us-doj.gov/odp/docs/HSEEPv2.pdf [Accessed 2006 Sep 8]

  28. Catlett C, Perl T, Jenckes M, et al. Training of clinicians for public health events relevant to bioterrorism preparedness (evidence report/technology assessment no. 51 prepared by Johns Hopkins Evidence-based Practice Center under contract no. 290-97-006). AHRQ pub. no. 02-E011. Rockville (MD): Agency for Healthcare Research and Quality, 2002

  29. Shadel BN, Rebmann T, Clements B, et al. Infection control practitioners perceptions about biological terrorism and emerging infections — effective planning for healthcare facilities. Am J Infect Control 2003; 31: 129–34

    Article  PubMed  Google Scholar 

  30. Shadel BN, Chen JJ, Newkirk RY, et al. Bioterrorism risk perceptions and educational needs of public health professionals before and after September 11, 2001: a national needs assessment survey. J Public Health Manag Pract 2004; 10: 282–9

    PubMed  Google Scholar 

  31. Sterling DA, Clements B, Rebmann T, et al. Occupational physician perceptions of bioterrorism. Int J Hyg Environ Health 2005; 208: 127–34

    Article  PubMed  Google Scholar 

  32. Evans RG. Physician perceptions of bioterrorism. St Louis (MO): Institute for Biosecurity, Saint Louis University School of Public Health, 2006. (Data on file)

  33. Freed HA, Milzman D, Freed M. Knowledge about the initial presentation of smallpox among emergency physicians in Washington, DC. Acad Emerg Med 2005; 12: 771–4

    Article  PubMed  Google Scholar 

  34. Kozma CM. Can smallpox response teams use the experience of disease management programs? Manag Care Interface 2003; 16(2): 45–6

    Google Scholar 

  35. Inglesby TV, Dennis DT, Henderson DA, et al. Plague as a biological weapon: medical and public health management. Working Group on Civilian Biodefense. JAMA 2000 May 3; 283(17): 2281–90

    Article  PubMed  CAS  Google Scholar 

  36. US Departments of the Army, Navy, and Air Force. NATO handbook on the medical aspects of NBC defensive operations. Washington, DC: Departments of the Army, Navy, and Air Force, 1996

  37. US Army Medical Research Institute of Infectious Diseases. Biological warfare and terrorism: medical issues and response. The blue book. Washington, DC: US Government Printing House, 2000

  38. Jernigan JA, Stephens DS, Ashford DA, et al. Bioterrorism-related inhalational anthrax: the first 10 cases reported in the United States. Emerg Infect Dis 2001; 7: 933–44

    Article  PubMed  CAS  Google Scholar 

  39. Inglesby TV, Henderson DA, Bartlett JG, et al. Anthrax as a biological weapon: medical and public health management. JAMA 1999; 281: 1735–45

    Article  PubMed  CAS  Google Scholar 

  40. Breman JG, Henderson DA. Diagnosis and management of smallpox. N Engl J Med 2002; 346: 1300–8

    Article  PubMed  Google Scholar 

  41. Henderson DA, Inglesby TV, Bartlett JG, et al. Smallpox as a biological weapon: medical and public health management. JAMA 1999; 282: 2127–37

    Article  Google Scholar 

  42. Dennis DT, Inglesby TV, Henderson DA, et al. Tularemia as a biological weapon: medical and public health management. JAMA 2001 Jun 6; 285(21): 2763–73

    Article  PubMed  CAS  Google Scholar 

  43. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management. JAMA 2001 285: 1059–70

    Article  PubMed  CAS  Google Scholar 

  44. Alibek K, Handelman S. Biohazard: the chilling true story of the largest covert biological weapons program in the world, told from the inside by the man who ran it. New York: Random House, 1999

    Google Scholar 

  45. Center for Nonproliferation Studies. Chemical and biological weapons: possession and programs past and present [online]. Available from URL: http://cns.miis.edu/research/cbw/possess.htm [Accessed 2006 Oct 2]

  46. Miller J, Engelberg S, Broad WJ. Germs: biological weapons and America’s secret war. Waterville (ME): GK Hall, 2002

    Google Scholar 

  47. Muyembe-Tamfum JJ, Kpasa M, Kiyungu C, et al. Ebola outbreak in Kikwit, Democratic Republic of Congo: discovery and control measures. J Infect Dis 1999; 179 Suppl. 1: S259–62

    Article  PubMed  Google Scholar 

  48. Borio L, Inglesby T, Peters CJ, et al. Hemorrhagic fever viruses as biological weapons: medical and public health management. JAMA 2002 May 8; 287(18): 2391–405

    Article  PubMed  Google Scholar 

  49. US Centers for Disease Control and Prevention. Update: investigation of bioterrorism-related anthrax and interim guidelines for exposure management and antimicrobial therapy, October 2001 [published erratum appears in MMWR Morb Mortal Wkly Rep 2001 Nov 2; 50 (43): 962]. MMWR Morb Mortal Wkly Rep 2001 Oct 26; 50(42): 909–19

    Google Scholar 

  50. Arnon SS, Schechter R, Inglesby TV, et al. Botulinum toxin as a biological weapon: medical and public health management [published erratum appears in JAMA 2001 Apr 25; 285 (16): 2081? JAMA 2001 Feb 28; 285(8): 1059–70

    Article  PubMed  CAS  Google Scholar 

Download references

Acknowledgments

No sources of funding were used to assist in the preparation of this review. The authors have no conflicts of interest that are directly relevant to the content of the review.

Author information

Authors and Affiliations

  1. Institute for Biosecurity, Saint Louis University, 3545 Lafayette Avenue, St Louis, Missouri, 63104, USA

    R. Gregory Evans (Director)

  2. Midwest Regional Center of Excellence for Biodefense and Emerging Infectious Diseases, Washington University School of Medicine, St Louis, Missouri, USA

    Steven J. Lawrence

Authors
  1. R. Gregory Evans
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Steven J. Lawrence
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to R. Gregory Evans.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Gregory Evans, R., Lawrence, S.J. Preparing for and Responding to Bioterrorist Attacks. Dis-Manage-Health-Outcomes 14, 265–274 (2006). https://doi.org/10.2165/00115677-200614050-00002

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00115677-200614050-00002

Keywords

Search

Navigation